Denver Investment Advisors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Denver Investment Advisors’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-12,939	Closed	-$102K	–	524
2015 Q4	$102K	Sell	12,939 -1,470	-10%	-$12.7K	﹤0.01%	483
2015 Q3	$122K	Buy	+14,409	New	+$133K	0.01%	494
2015 Q2	–	Sell	-21,031	Closed	-$294K	–	625
2015 Q1	$294K	Buy	+21,031	New	+$322K	0.01%	485

Other funds holding INFI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Denver Investment Advisors's INFI Position: Q1 2016 in Review

Denver Investment Advisors sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2016, closing a stake of 12,939 shares — an estimated $102K sold.

Denver Investment Advisors first reported a position in INFI in Q1 2015 and held it in 3 quarters. The position peaked at $294K in Q1 2015. 117 funds tracked by Wall St. Rank hold INFI as of Q1 2016.

Denver Investment Advisors reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
Denver Investment Advisors sold 12,939 Infinity Pharmaceuticals, Inc. shares in Q1 2016, an estimated $102K.
Denver Investment Advisors first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2015 and held it in 3 quarters.
Denver Investment Advisors's Infinity Pharmaceuticals, Inc. position peaked at $294K in Q1 2015.
117 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2016.

Based on Denver Investment Advisors's 13F filing for Q1 2016, filed 12 May 2016.